NEWS
Find a Professional: Explore Experts Across 197 Disciplines in 221 Countries!
Just Updated: Compare Your Institution (Live Data)
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025 (Updated Today)
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
Login
Register & Pricing
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
For Students
local_fire_department
Country Reports
person
Find a Professional
Carl Hamby
New York Medical College - Valhalla / United States
Medical and Health Sciences / Immunology
AD Scientific Index ID: 847543
Registration, Add Profile,
Premium Membership
Get Your Global Impact Certificate
Ranking &
Analysis
Job
Experiences
Education
Information
Published Books
Book Chapters
Articles
Presentations
Lessons
Projects
Co-Authors
Subject Leaders
Editorship, Referee &
Scientific Board
Patents /
Designs
Academic Grants
& Awards
Artistic
Activities
Certificate / Course
/ Trainings
Association &
Society Memberships
Contact, Office
& Social Media
person_outline
Carl Hamby's MOST POPULAR ARTICLES
1-)
Diagnostic and prognostic biomarkers in melanoma The Journal of clinical and aesthetic dermatology 7 (6), 13, 2014
2-)
Clinical Significance of αvβ3 Integrin and Intercellular Adhesion Molecule-1 Expression in Cutaneous Malignant Melanoma Lesions Cancer Research 57 (8), 1554-1560, 1997
3-)
Dynamics of mobilization and homing of endothelial progenitor cells after acute renal ischemia: modulation by ischemic preconditioning American Journal of Physiology-Renal Physiology 291 (1), F176-F185, 2006
4-)
Loss of β‐catenin expression associated with disease progression in malignant melanoma British Journal of Dermatology 145 (2), 210-216, 2001
5-)
IGF1R-and ROR1-specific CAR T cells as a potential therapy for high risk sarcomas PLoS One 10 (7), e0133152, 2015
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept